vs

Side-by-side financial comparison of Acadia Healthcare Company, Inc. (ACHC) and Tyler Technologies (TYL). Click either name above to swap in a different company.

Acadia Healthcare Company, Inc. is the larger business by last-quarter revenue ($829.0M vs $613.5M, roughly 1.4× Tyler Technologies). Tyler Technologies runs the higher net margin — 13.2% vs 0.5%, a 12.7% gap on every dollar of revenue. On growth, Tyler Technologies posted the faster year-over-year revenue change (8.6% vs 7.5%). Over the past eight quarters, Tyler Technologies's revenue compounded faster (6.5% CAGR vs 2.0%).

Acadia Healthcare Company, Inc. is an American provider of for-profit behavioral healthcare services. It operates a network of over 225 facilities across the United States and Puerto Rico.

Tyler Technologies, Inc. is an American technology company based in Plano, Texas, that provides proprietary software to the U.S. public sector. Tyler Technologies has offices in 17 states and one in Toronto, Ontario, Canada.

ACHC vs TYL — Head-to-Head

Bigger by revenue
ACHC
ACHC
1.4× larger
ACHC
$829.0M
$613.5M
TYL
Growing faster (revenue YoY)
TYL
TYL
+1.0% gap
TYL
8.6%
7.5%
ACHC
Higher net margin
TYL
TYL
12.7% more per $
TYL
13.2%
0.5%
ACHC
Faster 2-yr revenue CAGR
TYL
TYL
Annualised
TYL
6.5%
2.0%
ACHC

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
ACHC
ACHC
TYL
TYL
Revenue
$829.0M
$613.5M
Net Profit
$4.5M
$81.2M
Gross Margin
48.3%
Operating Margin
16.3%
Net Margin
0.5%
13.2%
Revenue YoY
7.5%
8.6%
Net Profit YoY
-50.8%
EPS (diluted)
$0.05
$1.88

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACHC
ACHC
TYL
TYL
Q1 26
$829.0M
$613.5M
Q4 25
$821.5M
$575.2M
Q3 25
$851.6M
$595.9M
Q2 25
$869.2M
$596.1M
Q1 25
$770.5M
$565.2M
Q4 24
$774.2M
$541.1M
Q3 24
$815.6M
$543.3M
Q2 24
$796.0M
$541.0M
Net Profit
ACHC
ACHC
TYL
TYL
Q1 26
$4.5M
$81.2M
Q4 25
$-1.2B
$65.5M
Q3 25
$36.2M
$84.4M
Q2 25
$30.1M
$84.6M
Q1 25
$8.4M
$81.1M
Q4 24
$32.6M
$65.2M
Q3 24
$68.1M
$75.9M
Q2 24
$78.5M
$67.7M
Gross Margin
ACHC
ACHC
TYL
TYL
Q1 26
48.3%
Q4 25
45.5%
Q3 25
47.2%
Q2 25
45.8%
Q1 25
47.3%
Q4 24
43.8%
Q3 24
43.7%
Q2 24
44.0%
Operating Margin
ACHC
ACHC
TYL
TYL
Q1 26
16.3%
Q4 25
-142.4%
13.0%
Q3 25
4.7%
16.4%
Q2 25
5.8%
16.0%
Q1 25
1.7%
15.8%
Q4 24
4.9%
13.2%
Q3 24
12.1%
15.2%
Q2 24
13.4%
14.4%
Net Margin
ACHC
ACHC
TYL
TYL
Q1 26
0.5%
13.2%
Q4 25
-143.3%
11.4%
Q3 25
4.3%
14.2%
Q2 25
3.5%
14.2%
Q1 25
1.1%
14.3%
Q4 24
4.2%
12.1%
Q3 24
8.4%
14.0%
Q2 24
9.9%
12.5%
EPS (diluted)
ACHC
ACHC
TYL
TYL
Q1 26
$0.05
$1.88
Q4 25
$-12.98
$1.50
Q3 25
$0.40
$1.93
Q2 25
$0.33
$1.93
Q1 25
$0.09
$1.84
Q4 24
$0.36
$1.48
Q3 24
$0.74
$1.74
Q2 24
$0.85
$1.57

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACHC
ACHC
TYL
TYL
Cash + ST InvestmentsLiquidity on hand
$158.5M
$346.4M
Total DebtLower is stronger
$2.5B
Stockholders' EquityBook value
$2.0B
$3.6B
Total Assets
$5.5B
$4.8B
Debt / EquityLower = less leverage
1.29×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACHC
ACHC
TYL
TYL
Q1 26
$158.5M
$346.4M
Q4 25
$133.2M
$1.1B
Q3 25
$118.7M
$950.8M
Q2 25
$131.4M
$892.3M
Q1 25
$91.2M
$807.4M
Q4 24
$76.3M
$768.0M
Q3 24
$82.1M
$544.3M
Q2 24
$77.2M
$258.0M
Total Debt
ACHC
ACHC
TYL
TYL
Q1 26
$2.5B
Q4 25
$2.5B
$599.7M
Q3 25
$2.3B
$599.2M
Q2 25
$2.3B
$598.8M
Q1 25
$2.2B
$598.4M
Q4 24
$2.0B
$597.9M
Q3 24
$1.9B
$597.5M
Q2 24
$1.8B
$597.1M
Stockholders' Equity
ACHC
ACHC
TYL
TYL
Q1 26
$2.0B
$3.6B
Q4 25
$1.9B
$3.7B
Q3 25
$3.1B
$3.6B
Q2 25
$3.1B
$3.6B
Q1 25
$3.0B
$3.5B
Q4 24
$3.1B
$3.4B
Q3 24
$3.0B
$3.3B
Q2 24
$3.0B
$3.1B
Total Assets
ACHC
ACHC
TYL
TYL
Q1 26
$5.5B
$4.8B
Q4 25
$5.5B
$5.6B
Q3 25
$6.4B
$5.5B
Q2 25
$6.3B
$5.4B
Q1 25
$6.1B
$5.2B
Q4 24
$6.0B
$5.2B
Q3 24
$5.9B
$5.0B
Q2 24
$5.7B
$4.8B
Debt / Equity
ACHC
ACHC
TYL
TYL
Q1 26
1.29×
Q4 25
1.28×
0.16×
Q3 25
0.74×
0.17×
Q2 25
0.74×
0.16×
Q1 25
0.72×
0.17×
Q4 24
0.64×
0.18×
Q3 24
0.62×
0.18×
Q2 24
0.62×
0.19×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACHC
ACHC
TYL
TYL
Operating Cash FlowLast quarter
$61.5M
$107.3M
Free Cash FlowOCF − Capex
$2.0M
FCF MarginFCF / Revenue
0.3%
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
13.78×
1.32×
TTM Free Cash FlowTrailing 4 quarters
$585.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACHC
ACHC
TYL
TYL
Q1 26
$61.5M
$107.3M
Q4 25
$-86.3M
$243.9M
Q3 25
$73.2M
$255.2M
Q2 25
$133.5M
$98.3M
Q1 25
$11.5M
$56.2M
Q4 24
$116.7M
$224.8M
Q3 24
$163.1M
$263.7M
Q2 24
$171.1M
$64.3M
Free Cash Flow
ACHC
ACHC
TYL
TYL
Q1 26
$2.0M
Q4 25
$-179.5M
$239.6M
Q3 25
$-63.0M
$251.3M
Q2 25
$-34.2M
$92.8M
Q1 25
$-163.2M
$53.8M
Q4 24
$-86.8M
$221.0M
Q3 24
$-27.1M
$260.8M
Q2 24
$16.9M
$57.7M
FCF Margin
ACHC
ACHC
TYL
TYL
Q1 26
0.3%
Q4 25
-21.8%
41.7%
Q3 25
-7.4%
42.2%
Q2 25
-3.9%
15.6%
Q1 25
-21.2%
9.5%
Q4 24
-11.2%
40.8%
Q3 24
-3.3%
48.0%
Q2 24
2.1%
10.7%
Capex Intensity
ACHC
ACHC
TYL
TYL
Q1 26
Q4 25
11.3%
0.8%
Q3 25
16.0%
0.7%
Q2 25
19.3%
0.9%
Q1 25
22.7%
0.4%
Q4 24
26.3%
0.7%
Q3 24
23.3%
0.5%
Q2 24
19.4%
1.2%
Cash Conversion
ACHC
ACHC
TYL
TYL
Q1 26
13.78×
1.32×
Q4 25
3.72×
Q3 25
2.02×
3.02×
Q2 25
4.43×
1.16×
Q1 25
1.37×
0.69×
Q4 24
3.58×
3.45×
Q3 24
2.39×
3.47×
Q2 24
2.18×
0.95×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ACHC
ACHC

Acute Inpatient Psychiatric Facilities$471.0M57%
Other$140.0M17%
Specialty Treatment Facilities$128.0M15%
Residential Treatment Facilities$90.0M11%

TYL
TYL

Subscriptions$429.7M70%
Maintenance$108.9M18%
Other$74.9M12%

Related Comparisons